🚨 #ClinicalTrials Plenary at #AACR25@DrUppaluri presents KEYNOTE-689 perioperative pembrolizumab SOC improves EFS in locally advanced resectable HNSCC
🔹Subgroup analysis: no EFS benefit in stage IVA
🔹mPR 13.7% in CPS >=10
🔹Lower rates of path high-risk features postoperatively in pembro arm
🔹Trend towards improved OS, but did not meet statistical significance at 1st interim analysis
#HNCSM
🚨 Come & join @royalmarsdenNHS for a 2-year fellowship to conduct clinical research in cancer in older adults in a very supportive team with the opportunity to register for a research degree at @ICR_London
Info available here: tinyurl.com/5fkr37b8
Closing date: 22/11/2024
#gerionc#bcsm
🚀 Already looking forward to the results of the IMPORTANT-trial, investigating lower starting doses of #CDK4/6 inhibitors and the role of the #geriatric assessment in older adults with mBC
Congratulations to the authors for enrolling this study!
tandfonline.com/doi/full/10.…
Dr Goggin and her co-investigators present a study revealing 57% cancer survivors have ⬇️ social networks. Only 37% of older patients had access to computer/internet 🖥️. ⬆️social isolation than general population. @GogginCaitriona#survonc#supponcdoi.org/10.1093/oncolo/oyae1…
We were delighted to be in @stjamesdublin today for this fantastic meeting with #TSJCI . @RoseAnnekenny1 in full flight presenting an overview of TILDA:
"The number of people with functional limitations will increase 5 fold by 2040"
Looking forward to further collaboration with colleagues in cancer to grow opportunities for longitudinal data collection in #cancer survivors in collaboration with @tilda_tcd
The meeting explored synergies in geriatric oncology research, focusing on cancer survivorship and its impact on older adults. Significant potential for collaboration to inform future services for this growing population #ageing#GeriatricOncology#CancerSurvivorship
🇪🇺🗣️If you’re a Healthcare Professional with experience in cancer service provision for patients with a physical or intellectual disability over 65 years-old - consider participating in this @IrishCancerSoc funded EuCan Study. 💙
Contact: Shauna Walsh: walshs89@tcd.ie
The EuCan study, funded by @IrishCancerSoc, is recruiting healthcare professionals with experience in cancer service provision for people over the age of 65, people with a physical disability or an intellectual disability.
See more details below!
Cardiovasular disorders - associated with cancer - different risk factors in cancer and highest in haematological cancers and lung. @AoPgbi@stjamesdublin@TrinityMed1
Hot off the press the new @ASCO@myESMO global curriculum recommendations for Cancer Care in Older Adults #gerionc
Every oncologist should have key competencies in geriatric care! We hope this gets integrated in programs globally @HansWildiers @SIOGorgascopubs.org/doi/full/10.120…
Do we have the right priorities in oncology #ESMO2023#ESMO23 - pictures taken a few minutes apart. Supportive care and Investigational therapy poster areas. Clinically these two are intertwined.
🎙️The next YSIOG forum will be held next week!🎙️
Date: Thursday November 2, 07:00 PM - 08:00 PM CET time
Location: Zoom
The Zoom link has been emailed to all YSIOG members. Looking forward to seeing you all next Thursday!